5-HT3受体在有氧运动调控黑质-海马神经环路改善PD小鼠认知损害中的作用及机制
结题报告
批准号:
31972914
项目类别:
面上项目
资助金额:
58.0 万元
负责人:
黄莺
依托单位:
学科分类:
感觉器官与运动生理
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
黄莺
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
帕金森病(PD)是最常见的运动障碍疾病。除运动症状外,认知记忆障碍等非运动症状(NMS)对患者的功能影响更为明显,因此成为治疗的新目标。但由于病因及机制不明,对症的药物治疗对认知障碍缺乏有效性,且副作用大。大量流行病学研究表明运动在延缓疾病进展,减轻NMS方面发挥作用。而5-HT3受体(5-HT3Rs)是运动诱导海马可塑性和神经发生的必要条件。我们以往的工作也证实了5-HT3Rs在认知记忆中的重要作用。但5-HT3Rs在运动改善PD认知记忆损害中的作用机制有待阐明。本课题将运用行为学、电生理、神经示踪和光遗传学等方法在PD小鼠模型上明确了该作用,并研究其在神经发生,突触可塑性,神经环路等方面的机制。首次探讨DA与5-HT3Rs相互作用的新机制。研究结果将有助于理解5-HT/DA系统crosstalk在运动改善PD认知障碍中的作用,并可能为PD认知功能障碍的治疗提供新的信息和方法。
英文摘要
Parkinson’s disease (PD) is the most common neurodegenerative disorder that mainly affects the motor system. In addition to its cardinal motor symptoms, a number of non-motor symptoms (NMS) such as cognitive dysfunction are also associated with PD, which has a more significant impact on patients’ quality-of-life. So its treatment is becoming a new target for therapy. However, as the cause of PD is not clear, current drug therapy based on symptomatic relief not only has side effects, but also lacks effectiveness in the treatment of cognitive dysfunction. Data from epidemiological studies has been accumulating to suggest that exercise may have a role to play in alleviating NMS of PD. 5-HT3 receptor is essential for exercise-induced hippocampal plasticity and neurogenesis. Our previous works also confirmed the important role of 5-HT3Rs in cognition and memory. However, the effect and mechanisms of 5-HT3Rs in exercise-ameliotrating PD cognitive impairment remains to be elucidated. In this study, using behavioral, electrophysiological, neuro-trace and optogenetics methods, we will determine this effect and study the mechanisms of neurogenesis, synaptic plasticity and neural circuits. A novel mechanism for the interaction of DA with the 5-HT3 receptor will also be explored. The results of the study will help to understand the role of 5-HT/DA crosstalk in exercise ameliorating cognitive impairment and may provide useful insights into the treatment of cognitive dysfunction in PD.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:DOI: 10.1111/cns.14611
发表时间:2023
期刊:CNS Neuroscience & Therapeutics
影响因子:5.5
作者:Duan GB;Wang JW;Sun HH;Dong ZY;Zhang Y;Wang ZX;Chen Y;Chen Y;Huang Y;Xu SC
通讯作者:Xu SC
DOI:doi: 10.1111/bph.15793
发表时间:2022
期刊:Br J Pharmacol
影响因子:--
作者:Yu Y;Li JJ;He XQ;Lai ZY;Hao R;Qi Y;Cao DQ;Fu M;Ma H;Xie QC;Sun M;Huang ZL;Jin LJ;Sun HH;Lu N;Wang R;Yung WH;Huang Y
通讯作者:Huang Y
DOI:doi.org/10.3389/fncel.2022.922750
发表时间:2022
期刊:Frontiers in Cellular Neuroscience
影响因子:5.3
作者:Zhan TT;Dong ZY;Yi LS;Zhang Y;Sun HH;Zhang HQ;Wang JW;Chen Y;Huang Y;Xu SC
通讯作者:Xu SC
5-HT3受体调控空间学习记忆的突触及分子机制研究
  • 批准号:
    31771175
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2017
  • 负责人:
    黄莺
  • 依托单位:
国内基金
海外基金